<DOC>
	<DOCNO>NCT02890082</DOCNO>
	<brief_summary>The rate patient spontaneous pregnancy report breast cancer 3 7 % , particularly treatment . Therefore , essential anticipate problem proposing use fertility preservation technique young patient prior gonadotoxic treatment . PRESAGE study offer patient few 40 , preserve fertility neoadjuvant adjuvant chemotherapy invasive breast cancer . The aim study evaluate feasibility ovarian stimulation emergency order delay start treatment . This stimulation combine gonadotropin tamoxifen follow oocyte retrieval . The patient may receive oocyte vitrification / embryonic . This procedure already do many country , French team , combine tamoxifen letrozole classic gonadotropin stimulation .</brief_summary>
	<brief_title>Preservation Fertility Ovarian Stimulation Associated With Tamoxifen , Prior Chemotherapy Breast Cancer</brief_title>
	<detailed_description>With 50 000 new case per year , breast cancer common cancer woman France . About quarter breast cancer occur menopause 7 % age 40 year . Due increase incidence breast cancer young woman decline age first pregnancy , unusual patient desire pregnancy treatment breast cancer . Among woman , use adjuvant therapy ( chemotherapy , hormone therapy , chemical castration ) common . Adjuvant neoadjuvant chemotherapy result significantly low recurrence rate increase survival patient , treatment could less long-term consequence , include ovarian function . Ovarian consequence therapeutic must also explain young patient . But seem information often inadequate poorly understood , patient deplore faced secondary infertility . The rate patient spontaneous pregnancy report breast cancer 3 7 % , particularly treatment . Therefore , essential anticipate problem proposing use fertility preservation technique young patient prior gonadotoxic treatment . PRESAGE study offer patient few 40 , preserve fertility neoadjuvant adjuvant chemotherapy invasive breast cancer . The aim study evaluate feasibility ovarian stimulation emergency order delay start treatment . This stimulation combine gonadotropin tamoxifen follow oocyte retrieval . The patient may receive oocyte vitrification / embryonic . This procedure already do many country , French team , combine tamoxifen letrozole classic gonadotropin stimulation .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Aged 18 40 infiltrate breast carcinoma histologically proven Indication adjuvant neoadjuvant chemotherapy T0T1T2T3 N0N1N2a M0 stag AMH ≥1 ng / mL / account antral follicle ≥ 5 HIV serology negative . breast cancer history History another cancer last 5 year , exception basal cell skin cancer squamous cell patient pregnancy pulmonary embolism 6 month deep vein thrombosis le 6 month .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>fertility</keyword>
	<keyword>chemotherapy</keyword>
</DOC>